Inviragen’s DENVax, dengue vaccine, enters second stage of an ongoing Phase 2 study
Fort Collins, Colorado vaccine company, Inviragen, announced this week that it is advancing it’s investigational dengue vaccine, DENVax into the second stage of the ongoing Phase 2 clinical study, according More...
Inviragen CEO, Dr. Dan Stinchcomb gives an update on the DENVax dengue fever vaccine
Photo/CDC/ Debora Cartagena It’s in the news on a regular basis these days, a dengue fever outbreak here, an epidemic there, even Europe experienced their first sustained transmission of dengue since the 1920′s More...
